Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardamom and Topical Roseomonas in Atopic Dermatitis
NCT06096857Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2024
- Primary completion
- Jan 2027
- Modality
- Small Molecules, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Roseomonas mucosa + cardamom seeds in atopic dermatitis (AD), sponsored by National Institute of Allergy and Infectious Diseases. Started Oct 2024; status: recruiting.
02
Drugs
Roseomonas mucosa + cardamom seeds
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06096857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06096857.